| BAX |
Report |
Adj. EPS (Q2 2026) |
BEAT |
pred ~$0.38-0.40 vs. cons $0.370 |
MEDIUM |
| BAX |
Report |
Total Revenue (Q2 2026) |
IN-LINE |
pred ~$2,800-2,830M vs. cons $2,793M |
MEDIUM |
| BAX |
Report |
Adj. Operating Margin (Q2 2026) |
IN-LINE |
pred ~10.5-11.5% vs. cons ~11.0% |
MEDIUM |
| BAX |
Guide |
FY 2026 Adj. EPS (FY2026) |
UNCHANGED |
guide ~$1.85-$2.05 midpoint $1.95 vs. cons $1.905 |
HIGH |
| BAX |
Guide |
FY 2026 Revenue (FY2026) |
UNCHANGED |
guide flat to +1% reported vs. cons $11,353M |
HIGH |
| BAX |
Guide |
FY 2026 Adj. Op. Margin (FY2026) |
UNCHANGED |
guide 13%-14% vs. cons ~13.3% |
HIGH |
| BAX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| BAX |
Return |
5-day cumulative residual |
-4.0% (FADE) |
FADE — estimates flat on reiteration; implied H2 math thin; momentum sellers dominate after +41% run into print |
MEDIUM |